MedTrace Logo

Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery

NCT04951752 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 307

Last updated 2021-07-07

No results posted yet for this study

Summary

The study will review data collected in 5 previously completed randomised controlled trials with a new primary outcome: to assess whether administration of the transmuscular quadratus lumborum block has an impact on the time an individual patient stays in the postanaesthesia care unit and how much opioid is consumed during this specified time.

Conditions

  • Anesthesia, Local

Interventions

DRUG

Ropivacaine injection

Transmuscular quadratus lumborum block - active

Sponsors & Collaborators

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Jens Børglum Neimann, MD, PhD · Associate Professor, Zealand University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-14
Primary Completion
2021-08-01
Completion
2021-08-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04951752 on ClinicalTrials.gov